comparemela.com
Home
Live Updates
Mscnrio - Breaking News
Pages:
Latest Breaking News On - Mscnrio - Page 1 : comparemela.com
Eftilagimod Alpha Novel Triplet Combination is Well Tolerated, Generates CRs in Soft Tissue Sarcoma
Eftilagimod alpha plus radiotherapy and pembrolizumab was safe and displayed initial activity in soft tissue sarcoma.
United-states
Warsaw
L67
Poland
Katarzyna-kozak
Maria-sklodowska-curie-national-research-institute-of-oncology
Department-of-soft-tissue-bone-sarcoma
Bone-sarcoma
Mscnrio
Eftilagimod-alpha
Radiotherapy
Pembrolizumab
vimarsana © 2020. All Rights Reserved.